CD44 and lung adenocarcinoma: Due to the different sex distribution of EGFR status in patients with lung adenocarcinoma in Taiwan, the association between CD44 polymorphisms and two EGFR hotspot mutations (L858R and exon19 in-frame deletion) in male patients was investigated.